Lung cancer treatment and outcomes are profoundly influenced by the tumor microenvironment (TME), particularly in resectable ...

Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...

Scientists have discovered that the Brazilian camu-camu berry, already known for its health benefits in fighting obesity and ...

The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...

Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...

University of Kentucky Markey Cancer Center researchers have discovered a promising new way to combat therapy-resistant ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

On a clear, windless day, Kamm and six friends hiked a winding trail to the top of the 1,347-foot peak. Sagebrush perfumed ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new evidence rev ...

Cullinan Therapeutics has announced that its lead asset has aced a midstage lung cancer trial—but the biotech is keeping the ...

BOSTON - Patients with lung nodules often have to undergo several procedures including biopsy and multiple surgeries, but a ...

Newer treatments target pathways like Delta-like ligand 3, poly-ADP-ribose polymerase, and histone deacetylase to address ...